Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James A Kaye

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
International Journal of Clinical Practice|May 17, 2017
Treatment patterns and outcomes of Stage IIIB/IIIC melanoma in France, Germany and the UK: A retrospective and prospective observational study (MELABIS)Mark Harries, Peter Mohr, Florent Grange, et al.
Cancer Epidemiology|June 12, 2017
Clinical outcomes of female breast cancer according to BRCA mutation statusDeirdre P Cronin-Fenton, Anders Kjærsgaard, Mette Nørgaard, et al.
Melanoma Research|August 12, 2017
Economic burden of advanced melanoma in France, Germany and the UK: a retrospective observational study (Melanoma Burden-of-Illness Study)Florent Grange, Peter Mohr, Mark Harries, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 31, 2015
Randomized controlled trials in relapsed/refractory follicular lymphoma: a systematic review and meta-analysisRachel L Police, Peter C Trask, Jianmin Wang, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 3, 2014
Randomized controlled trials in relapsed/refractory chronic lymphocytic leukemia: a systematic review and meta-analysisRachel L Police, Peter C Trask, Jianmin Wang, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|August 7, 2020
Treatment patterns, adverse events, and direct and indirect economic burden in a privately insured population of patients with HR+/HER2- metastatic breast cancer in the United StatesRavi K Goyal, Gebra Cuyun Carter, Saurabh P Nagar, et al.
Epidemiology (Cambridge, Mass.)|May 26, 2018
Value of Free-text Comments for Validating Cancer Cases Using Primary-care Data in the United KingdomAndrea V Margulis, Joan Fortuny, James A Kaye, et al.
Epidemiology (Cambridge, Mass.)|November 15, 2017
Validation of Cancer Cases Using Primary Care, Cancer Registry, and Hospitalization Data in the United KingdomAndrea V Margulis, Joan Fortuny, James A Kaye, et al.
Epidemiology (Cambridge, Mass.)|November 30, 2018
Proportions of Cancer Cases in Primary Care, Hospital, and Cancer Registry Data Among Patients Treated for Overactive BladderAndrea V Margulis, Joan Fortuny, James A Kaye, et al.
Journal of Gastrointestinal Oncology|August 9, 2019
Medical record review of transition to lanreotide following octreotide for neuroendocrine tumorsMuhammad Wasif Saif, Rohan Parikh, David Ray, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
International Journal of Clinical Practice|May 17, 2017
Treatment patterns and outcomes of Stage IIIB/IIIC melanoma in France, Germany and the UK: A retrospective and prospective observational study (MELABIS)Mark Harries, Peter Mohr, Florent Grange, et al.
Cancer Epidemiology|June 12, 2017
Clinical outcomes of female breast cancer according to BRCA mutation statusDeirdre P Cronin-Fenton, Anders Kjærsgaard, Mette Nørgaard, et al.
Melanoma Research|August 12, 2017
Economic burden of advanced melanoma in France, Germany and the UK: a retrospective observational study (Melanoma Burden-of-Illness Study)Florent Grange, Peter Mohr, Mark Harries, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 31, 2015
Randomized controlled trials in relapsed/refractory follicular lymphoma: a systematic review and meta-analysisRachel L Police, Peter C Trask, Jianmin Wang, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 3, 2014
Randomized controlled trials in relapsed/refractory chronic lymphocytic leukemia: a systematic review and meta-analysisRachel L Police, Peter C Trask, Jianmin Wang, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|August 7, 2020
Treatment patterns, adverse events, and direct and indirect economic burden in a privately insured population of patients with HR+/HER2- metastatic breast cancer in the United StatesRavi K Goyal, Gebra Cuyun Carter, Saurabh P Nagar, et al.
Epidemiology (Cambridge, Mass.)|May 26, 2018
Value of Free-text Comments for Validating Cancer Cases Using Primary-care Data in the United KingdomAndrea V Margulis, Joan Fortuny, James A Kaye, et al.
Epidemiology (Cambridge, Mass.)|November 15, 2017
Validation of Cancer Cases Using Primary Care, Cancer Registry, and Hospitalization Data in the United KingdomAndrea V Margulis, Joan Fortuny, James A Kaye, et al.
Epidemiology (Cambridge, Mass.)|November 30, 2018
Proportions of Cancer Cases in Primary Care, Hospital, and Cancer Registry Data Among Patients Treated for Overactive BladderAndrea V Margulis, Joan Fortuny, James A Kaye, et al.
Journal of Gastrointestinal Oncology|August 9, 2019
Medical record review of transition to lanreotide following octreotide for neuroendocrine tumorsMuhammad Wasif Saif, Rohan Parikh, David Ray, et al.
Pageof 11